Hepatic fibroblast growth factor 21 (FGF21), a major factor in regulating hepatic metabolism, glucose, fatty acid and insulin resistance, are increased in patients with NAFLD [62–65]. The gene discussed is FGF21; the disease is metabolic dysfunction-associated steatotic liver disease.